A Self‐Monitoring Single‐Atom Copper Nanocapsule for Cascade‐Responsive Tumor Cuproptosis Therapy
- 6 July 2026
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (37) , e4386021
Abstract
Cuproptosis represents a potent anticancer mechanism, yet its translation is hampered by the scarcity of tumor‐selective and efficient copper ion modulators. Herein, we develop a single‐atom copper‐based smart nanocapsule (SNC) that enables cascade‐responsive copper ion release within the tumor microenvironment (TME) for synergistic cuproptosis therapy and self‐monitoring. The SNCs are constructed by anchoring isolated copper atoms within a gold cluster/zeolite framework via the Cu‐imidazole/carboxyl coordination, guaranteeing atomic dispersion and high biostability. Upon encountering the weakly acidic and glutathione‐rich TME, the SNCs undergo sequential ligand protonation and competitive coordination, which synergistically triggers framework disassembly and controlled copper ion release. The intracellularly accumulated copper ions robustly activate the cuproptosis pathway and concurrently facilitate a specific fluorescence recovery of gold clusters for self‐reporting therapeutic monitoring. Both in vitro and in vivo assessments demonstrate high‐efficacy tumor therapy and imaging capabilities without eliciting systemic toxicity. This work pioneers a versatile cuproptosis‐induction platform with broad potentials for advancing diverse biomedical applications.Keywords
Funding Information
- National Natural Science Foundation of China (22274024)
- National Natural Science Foundation of China (22421002)
- National Natural Science Foundation of China (22334004)
- National Natural Science Foundation of China (22404022)
- Natural Science Foundation of Fujian Province (2024J01701)
- State Key Laboratory of Structural Chemistry (20250035)
This publication has 36 references indexed in Scilit:
- Evolving Platinum‐Copper Nanostructures for Enhanced Photothermal Therapy and Controlled Copper Release in Cancer TherapyAdvanced Functional Materials, 2025
- Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunitiesCancer Communications, 2025
- Tumor Microenvironment Reprogrammed Bimetallic Hybrid Nanostimulator for Triggering Radio‐Cuproptosis‐ImmunotherapyAdvanced Healthcare Materials, 2024
- Gold Nanocluster: A Photoelectric Converter for X‐Ray‐Activated ChemotherapyAdvanced Materials, 2024
- Copper‐Induced Supramolecular Peptide Assemblies for Multi‐Pathway Cell Death and Tumor InhibitionAngewandte Chemie International Edition, 2024
- Stimulus‐Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer ImmunotherapyAdvanced Science, 2024
- Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic TherapyAngewandte Chemie International Edition, 2023
- Matching Bidentate Ligand Anchoring: an Accurate Control Strategy for Stable Single‐Atom/ZIF NanocatalystsAdvanced Materials, 2022
- A New Class of NIR‐II Gold Nanocluster‐Based Protein Biolabels for In Vivo Tumor‐Targeted ImagingAngewandte Chemie International Edition, 2020
- Supramolecular Fluorescence Resonance Energy Transfer in Nucleobase‐Modified Fluorogenic RNA AptamersAngewandte Chemie International Edition, 2020